(19)
(11) EP 0 953 048 A1

(12)

(43) Date of publication:
03.11.1999 Bulletin 1999/44

(21) Application number: 97947824.0

(22) Date of filing: 31.12.1997
(51) International Patent Classification (IPC): 
A61K 39/ 395( . )
C07K 14/ 715( . )
C07K 14/ 735( . )
C12N 5/ 10( . )
G01N 33/ 53( . )
C07K 14/ 705( . )
C07K 14/ 725( . )
C07K 16/ 28( . )
C12N 15/ 12( . )
A61K 38/ 00( . )
(86) International application number:
PCT/IB1997/001610
(87) International publication number:
WO 1998/029543 (09.07.1998 Gazette 1998/27)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 31.12.1996 EP 19960402930

(71) Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
75654 Paris CĂ©dex 13 (FR)

(72) Inventors:
  • DAERON, Marc
    F-78460 Chevreuse (FR)
  • VIVIER, Eric
    F-13260 Cassis (FR)

(74) Representative: Peaucelle, Chantal 
Cabinet Armengaud Aine 3, avenue Bugeaud
75116 Paris
75116 Paris (FR)

   


(54) COMPOUNDS FOR MODULATING CELL NEGATIVE REGULATIONS AND BIOLOGICAL APPLICATIONS THEREOF